Which sector has the biggest momentum heading into earnings season?

The ASX 200 also posted a healthy gain over the month.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Some Australian market sectors are performing stronger than others as we head further into earnings season.  

The S&P/ASX 200 Index (ASX: XJO) posted a healthy 2.4% gain in July, while the All Ordinaries Index (ASX: XAO) climbed 2.6% higher over the month, Macquarie Group Ltd (ASX: MQG) data reveals.

"Australian equities rose in July, with the ASX 200 up +2.4%. The key theme of the month was the rotation from leaders to laggards, a phenomenon that often occurs at the start of a new financial year," Macquarie said in a note to investors.

The S&P/ASX 200 Resources Index (ASX: XJR) gained 4.5% over the month.

"Resources (+4.5%) had a strong month, supported by a rise in commodity prices," Macquarie said.

The strength in Industrial resources was relatively broad, with strength across Iron Ore. Fortescue Ltd (ASX: FMG) shares gained 16%.

Lithium, oil & gas, and Coal increases also supported the monthly gains. Mineral Resources Ltd (ASX: MIN) shares climbed 33% and Pilbara Minerals Ltd (ASX: PLS) shares increased 20%. 

Woodside Energy Group Ltd (ASX: WDS) shares climbed 13% higher, and Whitehaven Coal Ltd (ASX: WHC) shares jumped 19%.

"Consistent with the strength in Resources, China's stocks outperformed +3.5%," the broker said.

A group of people excitedly cheering at a horse race.

Image source: Getty Images

Strongest momentum by sector

By sector, health came out on top as the clear winner. The S&P/ASX 200 Health Care Index (ASX: XHJ) climbed 8.7% over the course of July, drastically outpacing the benchmark

The sector's gains were driven by index heavyweight CSL Ltd (ASX: CSL) shares, which climbed 13%.

"[CSL] was likely a key beneficiary of investors shifting some large cap money out of banks," the broker note said. 

Pro Medicus Ltd (ASX: PME) and Resmed Inc (ASX: RMD) shares were also strong performers. The share prices increased by 13% and 8%, respectively.

The energy, technology, and utilities sectors came next in line. The S&P/ASX 200 Energy Index (ASX: XEJ) jumped 5.4% over the month. The S&P/ASX 200 Information Technology Index (ASX: XIJ) and S&P/ASX 200 Utilities Index (ASX: XUJ) climbed 5.2% and 5.1% higher, respectively.

The S&P/ASX 200 Materials Index (ASX: XMJ) climbed 4.1% in July, while the S&P/ASX 200 Real Estate Index (ASX: XRE) and the S&P/ASX 200 Consumer Discretionary Index (ASX: XDJ) rose by 3.2% and 3%, respectively.

Industrials and communication services posted some gains over the course of the month, albeit at a lower level. The S&P/ASX 200 Industrials Index (ASX: XNJ) rose by 2.7% and the S&P/ASX 200 Communication Services Index (ASX: XTJ) increased by 2.2%. 

Meanwhile, the worst-performing ASX sector was financials, with the S&P/ASX 200 Financials Index (ASX: XFJ) falling 1%.

The second-worst sector was consumer staples, with the S&P/ASX 200 Consumer Staples Index (ASX: XSJ) posting a small 0.4% gain.

Macquarie's outlook

The broker said in its note to investors:

Our bottom-up FY25 EPSg forecast is a decline of 3.2%. If this proves correct, it will be the third year in a row of declining earnings. At this point, our team forecast a relatively weak EPSg rebound of +2.2% in FY26. Unfortunately, August is typically the peak month for downgrades, as conservative guidance re-sets the earnings bar lower. But driven by global rate cuts and economic momentum, we think Australia's economic activity will improve, and support earnings upgrades over FY26.

Seasonality outlook. After the positive returns that typically occur in July, the next two months are likely to be disappointing. Over the last decade, August has been the third worst for returns, while September is the worst (and usually negative). To the extent this negative seasonality plays out again in 2025, it would provide another opportunity for investors to buy in expectation of a pick-up in growth in FY26.

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Macquarie Group, and ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Macquarie Group and ResMed. The Motley Fool Australia has recommended CSL and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Sector

Woman flexes muscles after donating blood.
Healthcare Shares

CSL shares: 1 number that investors shouldn't ignore

This one number has me rethinking a CSL investment.

Read more »

Shocked woman reacts to news on her computer.
Technology Shares

Why did WiseTech shares just crash 10%?

Find out what caused today's sudden selloff.

Read more »

Two CEOs shaking hands on a deal.
Resources Shares

European Lithium updates merger terms with Critical Metals Corp

European Lithium has updated its merger terms with Critical Metals, introducing a floating share ratio and targeting completion in October…

Read more »

Different Australian dollar notes in the palm of two hands, symbolising dividends.
Financial Shares

WAM Global lifts dividend despite underperforming global benchmark

WAM Global lifts its FY26 dividend while reporting an after-tax loss and portfolio underperformance.

Read more »

Gas share price represented by a rising share price chart.
Energy Shares

Macquarie tips this ASX gas company to jump more than 50%

Everything's lining up well for this gas producer.

Read more »

A woman's hair is blown back and her face is in shock at this big news.
Healthcare Shares

CSL shares rebound 79% from multi-year low: Here's what brokers tip next

The ASX biotech company announced its FY26 results yesterday.

Read more »

A woman leans forward with her hand behind her ear, as if trying to hear information.
Healthcare Shares

Buy $5,000 of Cochlear shares today and it could be worth this much in 12 months

Find out what brokers tip for this ASX healthcare stock next.

Read more »

Woman pointing to a hologram of a world map with finance graphs and related themes.
Resources Shares

Would I invest $5,000 into Rio Tinto shares this week?

The shares have already run hard, but I still see plenty to like in the years ahead.

Read more »